A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

NCT01422330 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

211

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV) Infection

Interventions

DRUG: Etravirine

Sponsor

Janssen R&D Ireland